mainbody.htm
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
____________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): January 13,
2010
Skinvisible,
Inc.
(Exact
name of registrant as specified in its charter)
|
Nevada
|
000-25911
|
88-0344219
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
|
6320 South Sandhill Road Suite 10, Las Vegas,
NV
|
89120
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: 702-433-7154
|
___________________________________________________
(Former
name or former address, if changed since last
report)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
[
] Written communications pursuant to
Rule 425 under the Securities Act (17CFR 230.425)
[
] Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
[
] Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[
] Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
SECTION
7 – Regulation FD Disclosure
Item
7.01 Regulation
FD Disclosure
On July
17, 2009, we issued a press release announcing that one of our licensees made an
agreement with Walgreens, a copy of which is attached as Exhibit 99.1 to this
Current Report on Form 8-K.
The
information in Item 7.01 of this Current Report on Form 8-K (including Exhibit
99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933 or the Exchange Act, except as
expressly set forth by specific reference in such a filing.
SECTION
9 – Financial Statements and Exhibits
Item
9.01 Financial
Statements and Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Skinvisible,
Inc.
/s/Terry
Howlett
Terry
Howlett
Chief
Executive Officer
Date: January 13, 2010